Alector (ALEC) Accumulated Expenses (2018 - 2026)
Alector's (ALEC) quarterly Accumulated Expenses came in at $7.0 million in Q2 2026, down 50.5% year-over-year from $14.2 million in Q2 2025, and down 35.63% quarter-over-quarter from $10.9 million in Q1 2026.
Analysis
Alector (ALEC) Accumulated Expenses (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Accumulated Expenses for 9 consecutive years, with $7.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Accumulated Expenses fell 50.5% year-over-year to $7.0 million in Q2 2026; TTM through Jun 2026 was $7.0 million, a 50.5% decrease from a year earlier, with the FY2025 full-year figure at $19.3 million, down 33.2% from the prior year.
- Accumulated Expenses was $7.0 million for Q2 2026 at Alector, down from $10.9 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $30.4 million in Q3 2023 and troughed at $7.0 million in Q2 2026.
- A 5-year average of $21.2 million and a median of $21.5 million in 2022 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses surged 30.99% in 2023 and tumbled 50.5% in 2026, its largest moves.
- Over 5 years, Accumulated Expenses stood at $27.8 million in 2022, then advanced by 9.39% to $30.4 million in 2023, then declined by 4.9% to $28.9 million in 2024, then slumped by 33.2% to $19.3 million in 2025, then tumbled by 63.54% to $7.0 million in 2026.
- The last three Accumulated Expenses figures came in at $7.0 million (Q2 2026), $10.9 million (Q1 2026), and $19.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.04 Mn |
| Mar 31, 2026 | 10.93 Mn |
| Dec 31, 2025 | 19.30 Mn |
| Sep 30, 2025 | 18.33 Mn |
| Jun 30, 2025 | 14.22 Mn |
| Mar 31, 2025 | 17.32 Mn |
| Dec 31, 2024 | 28.89 Mn |
| Sep 30, 2024 | 25.70 Mn |
| Jun 30, 2024 | 23.08 Mn |
| Mar 31, 2024 | 19.39 Mn |
| Dec 31, 2023 | 30.38 Mn |
| Sep 30, 2023 | 30.42 Mn |
| Jun 30, 2023 | 22.92 Mn |
| Mar 31, 2023 | 18.58 Mn |
| Dec 31, 2022 | 27.77 Mn |
| Sep 30, 2022 | 23.23 Mn |
| Jun 30, 2022 | 23.71 Mn |
| Mar 31, 2022 | 20.04 Mn |
| Dec 31, 2021 | 27.46 Mn |
| Sep 30, 2021 | 20.59 Mn |